{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:36:05Z","timestamp":1783690565806,"version":"3.55.0"},"reference-count":137,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Clinics of North America: Equine Practice"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.cveq.2025.08.011","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:20:27Z","timestamp":1758770427000},"page":"653-674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adverse Effects and Drug Reactions in Equids"],"prefix":"10.1016","volume":"41","author":[{"given":"Katherine E.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cveq.2025.08.011_bib1","series-title":"StatPearls [Internet]","article-title":"Adverse drug reactions. 2024","author":"Kommu","year":"2025"},{"key":"10.1016\/j.cveq.2025.08.011_bib2","unstructured":"Pichler WJ. Drug hypersensitivity: classification and clinical features. Uptodate, Available at: https:\/\/www.uptodate.com\/contents\/drug-hypersensitivity-classification-and-clinical-features (Accessed 16 September 2025) 2019."},{"key":"10.1016\/j.cveq.2025.08.011_bib3","series-title":"Hypersensitivity. Essentials of veterinary immunology and immunopathology","first-page":"49","author":"Chauhan","year":"2024"},{"key":"10.1016\/j.cveq.2025.08.011_bib4","author":"Association"},{"issue":"4","key":"10.1016\/j.cveq.2025.08.011_bib5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.2042-3306.1997.tb03124.x","article-title":"Clostridium difficile associated with acute colitis in mature horses treated with antibiotics","volume":"29","author":"B\u00e4verud","year":"1997","journal-title":"Equine Vet J"},{"issue":"11","key":"10.1016\/j.cveq.2025.08.011_bib6","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2746\/095777309X476871","article-title":"Antimicrobial associated diarrhoea in the horse. Part 1: overview, pathogenesis and risk factors","volume":"21","author":"McGorum","year":"2009","journal-title":"Equine Vet Educ"},{"issue":"1","key":"10.1016\/j.cveq.2025.08.011_bib7","doi-asserted-by":"crossref","DOI":"10.2746\/095777309X4710","article-title":"Antimicrobial associated diarrhoea in the horse. Part 2: which antimicrobials are associated with AAD in the horse?","volume":"22","author":"McGorum","year":"2010","journal-title":"Equine Vet Educ"},{"issue":"1","key":"10.1016\/j.cveq.2025.08.011_bib8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/evj.13570","article-title":"Characterisation of faecal microbiota in horses medicated with oral doxycycline hyclate","volume":"55","author":"Chapuis","year":"2023","journal-title":"Equine Vet J"},{"issue":"8","key":"10.1016\/j.cveq.2025.08.011_bib9","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3390\/ani12081013","article-title":"Effects of intravenous antimicrobial drugs on the equine fecal microbiome","volume":"12","author":"Liepman","year":"2022","journal-title":"Animals"},{"issue":"6","key":"10.1016\/j.cveq.2025.08.011_bib10","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.3390\/ani11061807","article-title":"Alterations in the fecal microbiome and metabolome of horses with antimicrobial-associated diarrhea compared to antibiotic-treated and non-treated healthy case controls","volume":"11","author":"Arnold","year":"2021","journal-title":"Animals"},{"key":"10.1016\/j.cveq.2025.08.011_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12917-015-0335-7","article-title":"Changes in the equine fecal microbiota associated with the use of systemic antimicrobial drugs","volume":"11","author":"Costa","year":"2015","journal-title":"BMC Vet Res"},{"issue":"6","key":"10.1016\/j.cveq.2025.08.011_bib12","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2885.2010.01167.x","article-title":"Pharmacokinetics and toxicity of ciprofloxacin in adult horses","volume":"33","author":"Yamarik","year":"2010","journal-title":"J Vet Pharmacol Therapeut"},{"issue":"2","key":"10.1016\/j.cveq.2025.08.011_bib13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.2042-3306.2012.00595.x","article-title":"Antimicrobial-associated diarrhoea in three equine referral practices","volume":"45","author":"Barr","year":"2013","journal-title":"Equine Vet J"},{"issue":"3","key":"10.1016\/j.cveq.2025.08.011_bib14","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2460\/javma.1999.214.03.382","article-title":"Characteristics and risk factors for failure of horses with acute diarrhea to survive: 122 cases (1990\u20131996)","volume":"214","author":"Cohen","year":"1999","journal-title":"J Am Vet Med Assoc"},{"issue":"4","key":"10.1016\/j.cveq.2025.08.011_bib15","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1939-1676.1996.tb02059.x","article-title":"Case control and historical cohort study of diarrhea associated with administration of trimethoprim-potentiated sulphonamides to horses and ponies","volume":"10","author":"Wilson","year":"1996","journal-title":"J Vet Intern Med"},{"issue":"6","key":"10.1016\/j.cveq.2025.08.011_bib16","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.2042-3306.1998.tb04523.x","article-title":"Clostridium difficile associated with acute colitis in mares when their foals are treated with erythromycin and rifampicin for Rhodococcus equi pneumonia","volume":"30","author":"B\u00e5verud","year":"1998","journal-title":"Equ Vet J"},{"issue":"2","key":"10.1016\/j.cveq.2025.08.011_bib17","first-page":"168","article-title":"Lincomycin-induced severe colitis in ponies: association with Clostridium cadaveris","volume":"56","author":"Staempfli","year":"1992","journal-title":"Can J Vet Res"},{"issue":"5","key":"10.1016\/j.cveq.2025.08.011_bib18","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1939-1676.2004.tb02613.x","article-title":"Experimental Clostridium difficile enterocolitis in foals","volume":"18","author":"Arroyo","year":"2004","journal-title":"J Vet Intern Med"},{"issue":"4","key":"10.1016\/j.cveq.2025.08.011_bib19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.2042-3292.2002.tb00167.x","article-title":"Suspected ciprofloxacin-induced colitis in four horses","volume":"14","author":"Weese","year":"2002","journal-title":"Equine Vet Educ"},{"issue":"23","key":"10.1016\/j.cveq.2025.08.011_bib20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/vr.142.23.635","article-title":"Use of metronidazole in equine acute idiopathic toxaemic colitis","volume":"142","author":"McGorum","year":"1998","journal-title":"Vet Rec"},{"issue":"5","key":"10.1016\/j.cveq.2025.08.011_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232905","article-title":"The cecal and fecal microbiomes and metabolomes of horses before and after metronidazole administration","volume":"15","author":"Arnold","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.cveq.2025.08.011_bib22","doi-asserted-by":"crossref","first-page":"skaf005","DOI":"10.1093\/jas\/skaf005","article-title":"Influence of Saccharomyces cerevisiae CNCM I-1077 on the fecal pH, markers of gut permeability, fecal microbiota, and markers of systemic inflammation in sedentary horses fed a high-starch diet","volume":"103","author":"Carter","year":"2025","journal-title":"J Anim Sci"},{"issue":"5","key":"10.1016\/j.cveq.2025.08.011_bib23","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/vr.100833","article-title":"Saccharomyces boulardii viability and efficacy in horses with antimicrobial-induced diarrhoea","volume":"172","author":"Boyle","year":"2013","journal-title":"Vet Rec"},{"key":"10.1016\/j.cveq.2025.08.011_bib24","unstructured":"Vivrette S, Bostian A, Bermingham E, Papich M. Quinolone-induced arthropathy in neonatal foals. Proceedings of the 47th Annual Convention of the American Association of Equine Practitioners, San Diego, CA. 2001:376-377."},{"issue":"1","key":"10.1016\/j.cveq.2025.08.011_bib25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/evj.13131","article-title":"Administration of enrofloxacin during late pregnancy failed to induce lesions in the resulting newborn foals","volume":"52","author":"Ellerbrock","year":"2020","journal-title":"Equ Vet J"},{"issue":"10","key":"10.1016\/j.cveq.2025.08.011_bib26","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.2460\/javma.2000.217.1514","article-title":"Effect of long-term administration of an injectable enrofloxacin solution on physical and musculoskeletal variables in adult horses","volume":"217","author":"Bertone","year":"2000","journal-title":"J Am Vet Med Assoc"},{"issue":"5","key":"10.1016\/j.cveq.2025.08.011_bib27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2885.1999.00224.x","article-title":"Tolerability of orally administered enrofloxacin in adult horses: a pilot study","volume":"22","author":"Gigu\u00e8re","year":"1999","journal-title":"J Vet Pharmacol Therapeut"},{"issue":"8","key":"10.1016\/j.cveq.2025.08.011_bib28","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2460\/ajvr.1998.59.08.1055","article-title":"Effect of intravenous calcium administration on gentamicin-induced nephrotoxicosis in ponies","volume":"59","author":"Brashier","year":"1998","journal-title":"Am J Vet Res"},{"issue":"10","key":"10.1016\/j.cveq.2025.08.011_bib29","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3390\/ph16101365","article-title":"Vitamin E and silymarin reduce oxidative tissue damage during gentamycin-induced nephrotoxicity","volume":"16","author":"Georgiev","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10.1016\/j.cveq.2025.08.011_bib30","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1111\/jvim.16221","article-title":"Gentamicin-induced sensorineural auditory loss in healthy adult horses","volume":"35","author":"Aleman","year":"2021","journal-title":"J Vet Intern Med"},{"issue":"1","key":"10.1016\/j.cveq.2025.08.011_bib31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.2042-3292.2003.tb00208.x","article-title":"Choke, pleuropneumonia and suspected gentamicin vestibulotoxicity in a horse","volume":"15","author":"Dacre","year":"2003","journal-title":"Equine Vet Educ"},{"issue":"1","key":"10.1016\/j.cveq.2025.08.011_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2460\/javma.1993.203.01.105","article-title":"Hemodialysis for treatment of oxytetracycline-induced acute renal failure in a neonatal foal","volume":"203","author":"Vivrette","year":"1993","journal-title":"J Am Vet Med Assoc"},{"issue":"4","key":"10.1016\/j.cveq.2025.08.011_bib33","first-page":"160","article-title":"Rhabdomyolysis and acute renal failure associated with oxytetracycline administration in two neonatal foals affected by flexural limb deformity","volume":"7","author":"Ellero","year":"2020","journal-title":"Vet Sci"},{"key":"10.1016\/j.cveq.2025.08.011_bib34","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1751-0813.1973.tb02359.x","article-title":"Collapse following intravenous administration of oxytetracycline in two horses","volume":"49","author":"Potter","year":"1973","journal-title":"Austrialian Veterinary Journal"},{"issue":"1","key":"10.1016\/j.cveq.2025.08.011_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.2042-3306.1992.tb02777.x","article-title":"Cardiovascular effects and fatalities associated with intravenous administration of doxycycline to horses and ponies","volume":"24","author":"Riond","year":"1992","journal-title":"Equine Vet J"},{"issue":"1","key":"10.1016\/j.cveq.2025.08.011_bib36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/jvim.12030","article-title":"Efficacy of mass antimicrobial treatment of foals with subclinical pulmonary abscesses associated with Rhodococcus equi","volume":"27","author":"Venner","year":"2013","journal-title":"J Vet Intern Med"},{"issue":"5","key":"10.1016\/j.cveq.2025.08.011_bib37","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/evj.12481","article-title":"Macrolide-induced hyperthermia in foals: role of impaired sweat responses","volume":"48","author":"Stieler","year":"2016","journal-title":"Equine Vet J"},{"issue":"5","key":"10.1016\/j.cveq.2025.08.011_bib38","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/evj.12677","article-title":"Effects of clarithromycin, azithromycin and rifampicin on terbutaline-induced sweating in foals","volume":"49","author":"Stieler Stewart","year":"2017","journal-title":"Equine Vet J"},{"issue":"1","key":"10.1016\/j.cveq.2025.08.011_bib39","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/jvim.12504","article-title":"Efficacy of gamithromycin for the treatment of foals with mild to moderate bronchopneumonia","volume":"29","author":"Hildebrand","year":"2015","journal-title":"J Vet Intern Med"},{"issue":"2","key":"10.1016\/j.cveq.2025.08.011_bib40","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.tvjl.2006.08.016","article-title":"Evaluation of tulathromycin in the treatment of pulmonary abscesses in foals","volume":"174","author":"Venner","year":"2007","journal-title":"Vet J"},{"issue":"5","key":"10.1016\/j.cveq.2025.08.011_bib41","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/jvp.12968","article-title":"Pharmacokinetics and pulmonary distribution of draxxin\u00ae(tulathromycin) in healthy adult horses","volume":"44","author":"Leventhal","year":"2021","journal-title":"J Vet Pharmacol Therapeut"},{"issue":"2","key":"10.1016\/j.cveq.2025.08.011_bib42","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cveq.2010.04.001","article-title":"Corticosteroid-associated laminitis","volume":"26","author":"Bailey","year":"2010","journal-title":"Vet Clin Equine Pract"},{"issue":"5","key":"10.1016\/j.cveq.2025.08.011_bib43","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/evj.13361","article-title":"Intrasynovial triamcinolone treatment is not associated with incidence of acute laminitis","volume":"53","author":"Haseler","year":"2021","journal-title":"Equine Vet J"},{"issue":"1","key":"10.1016\/j.cveq.2025.08.011_bib44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/evj.12565","article-title":"Does oral prednisolone treatment increase the incidence of acute laminitis?","volume":"49","author":"Jordan","year":"2017","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2025.08.011_bib45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.prevetmed.2016.11.012","article-title":"Disease and pharmacologic risk factors for first and subsequent episodes of equine laminitis: a cohort study of free-text electronic medical records","volume":"136","author":"Welsh","year":"2017","journal-title":"Prev Vet Med"},{"issue":"6","key":"10.1016\/j.cveq.2025.08.011_bib46","first-page":"617","article-title":"Diagnostic evaluation of insulin and glucose dynamics in light-breed horses receiving dexamethasone","volume":"63","author":"Timko","year":"2022","journal-title":"Can Vet J"},{"issue":"2","key":"10.1016\/j.cveq.2025.08.011_bib47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2746\/042516409X475779","article-title":"Equine laminitis: induced by 48 h hyperinsulinaemia in standardbred horses","volume":"42","author":"de Laat","year":"2010","journal-title":"Equine Vet J"},{"issue":"21","key":"10.1016\/j.cveq.2025.08.011_bib48","article-title":"Non-steroidal anti-inflammatory drugs and associated toxicities in horses","volume":"12","author":"Flood","year":"2022","journal-title":"Animals (Basel)"},{"issue":"3","key":"10.1016\/j.cveq.2025.08.011_bib49","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1053\/j.gastro.2017.10.049","article-title":"Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs","volume":"154","author":"Bjarnason","year":"2018","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cveq.2025.08.011_bib50","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/evj.13323","article-title":"Impact of concurrent treatment with omeprazole on phenylbutazone-induced equine gastric ulcer syndrome (EGUS)","volume":"53","author":"Ricord","year":"2021","journal-title":"Equine Vet J"},{"issue":"3","key":"10.1016\/j.cveq.2025.08.011_bib51","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/evj.13962","article-title":"Clinical effects of a combination of phenylbutazone and omeprazole on chronic lameness in Mongolian horses","volume":"56","author":"Li","year":"2024","journal-title":"Equine Vet J"},{"issue":"1","key":"10.1016\/j.cveq.2025.08.011_bib52","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40168-024-01785-1","article-title":"Integrated analysis of gut metabolome, microbiome, and exfoliome data in an equine model of intestinal injury","volume":"12","author":"Whitfield-Cargile","year":"2024","journal-title":"Microbiome"},{"issue":"5","key":"10.1016\/j.cveq.2025.08.011_bib53","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1111\/jvim.15897","article-title":"The effect of combined carprofen and omeprazole administration on gastrointestinal permeability and inflammation in dogs","volume":"34","author":"Jones","year":"2020","journal-title":"J Vet Intern Med"},{"issue":"1","key":"10.1016\/j.cveq.2025.08.011_bib54","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2460\/ajvr.80.1.79","article-title":"Investigation of effects of omeprazole on the fecal and gastric microbiota of healthy adult horses","volume":"80","author":"Tyma","year":"2019","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cveq.2025.08.011_bib55","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/eve.12454","article-title":"Nonsteroidal anti-inflammatory drug associated right dorsal colitis in the horse","volume":"29","author":"Davis","year":"2017","journal-title":"Equine Vet Educ"},{"issue":"6","key":"10.1016\/j.cveq.2025.08.011_bib56","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1111\/jvim.16884","article-title":"Right dorsal colitis in horses: a multicenter retrospective study of 35 cases","volume":"37","author":"Flood","year":"2023","journal-title":"J Vet Intern Med"},{"issue":"1","key":"10.1016\/j.cveq.2025.08.011_bib57","doi-asserted-by":"crossref","DOI":"10.2460\/ajvr.23.08.0182","article-title":"Nonsteroidal antiinflammatory drugs reduce anion secretion and increase apoptosis in equine colonic mucosa ex vivo","volume":"85","author":"Vinijkumthorn","year":"2024","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cveq.2025.08.011_bib58","first-page":"141","article-title":"Freedom of information summary, original new animal drug application","author":"USFaD","year":"2014","journal-title":"NADA"},{"key":"10.1016\/j.cveq.2025.08.011_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.jevs.2022.104007","article-title":"Retrospective analysis of the use of tiludronate in equine practice: safety on 1804 horses, efficacy on 343 horses","volume":"115","author":"Tischmacher","year":"2022","journal-title":"J Equine Vet Sci"},{"key":"10.1016\/j.cveq.2025.08.011_bib60","first-page":"141","article-title":"Freedom of information summary, original new animal drug application","author":"USFaD","year":"2014","journal-title":"NADA"},{"issue":"2","key":"10.1016\/j.cveq.2025.08.011_bib61","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2885.1983.tb00388.x","article-title":"Influence of acepromazine maleate on the equine haematocrit","volume":"6","author":"Parry","year":"1983","journal-title":"J Vet Pharmacol Therapeut"},{"issue":"3","key":"10.1016\/j.cveq.2025.08.011_bib62","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2885.1993.tb00183.x","article-title":"Disposition, bioavailability and clinical efficacy of orally administered acepromazine in the horse","volume":"16","author":"Hashem","year":"1993","journal-title":"J Vet Pharmacol Therapeut"},{"issue":"5","key":"10.1016\/j.cveq.2025.08.011_bib63","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1751-0813.1982.tb02761.x","article-title":"Hypotension in the horse induced by acepromazine maleate","volume":"59","author":"Parry","year":"1982","journal-title":"Aust Vet J"},{"issue":"2","key":"10.1016\/j.cveq.2025.08.011_bib64","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.2042-3306.1978.tb02227.x","article-title":"Priapism after sedation, neuroleptanalgesia and anaesthesia in the horse","volume":"10","author":"Pearson","year":"1978","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2025.08.011_bib65","first-page":"E1","article-title":"Perianesthetic use of acepromazine in the male equine: a retrospective study and opinion poll","volume":"39","author":"Driessen","year":"2010","journal-title":"Vet Surg"},{"issue":"1","key":"10.1016\/j.cveq.2025.08.011_bib66","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.2042-3306.2010.00107.x","article-title":"Contemporary use of acepromazine in the anaesthetic management of male horses and ponies: a retrospective study and opinion poll","volume":"43","author":"Driessen","year":"2011","journal-title":"Equine Vet J"},{"issue":"5","key":"10.1016\/j.cveq.2025.08.011_bib67","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1467-2995.2011.00641.x","article-title":"Persistent penile erection (priapism) after acepromazine premedication in a gelding","volume":"38","author":"Taylor","year":"2011","journal-title":"Vet Anaesth Analg"},{"issue":"3","key":"10.1016\/j.cveq.2025.08.011_bib68","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1476-4431.2007.00231.x","article-title":"Administration of acepromazine maleate to 31 dogs with a history of seizures","volume":"17","author":"McConnell","year":"2007","journal-title":"J Vet Emerg Crit Care"},{"issue":"4","key":"10.1016\/j.cveq.2025.08.011_bib69","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5326\/0420283","article-title":"A retrospective study on the use of acepromazine maleate in dogs with seizures","volume":"42","author":"Tobias","year":"2006","journal-title":"J Am Anim Hosp Assoc"},{"issue":"8","key":"10.1016\/j.cveq.2025.08.011_bib70","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/jat\/bkt073","article-title":"Quantitation of fluphenazine in equine serum following fluphenazine decanoate administration","volume":"37","author":"Costello","year":"2013","journal-title":"J Anal Toxicol"},{"issue":"1","key":"10.1016\/j.cveq.2025.08.011_bib71","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2460\/javma.229.1.104","article-title":"Adverse extrapyramidal effects in four horse given fluphenazine decanoate","volume":"229","author":"Baird","year":"2006","journal-title":"J Am Vet Med Assoc"},{"issue":"8","key":"10.1016\/j.cveq.2025.08.011_bib72","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.2460\/javma.1989.195.08.1128","article-title":"Extrapyramidal side effects caused by fluphenazine decanoate in a horse","volume":"195","author":"Kauffman","year":"1989","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.cveq.2025.08.011_bib73","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.2042-3306.1990.tb04227.x","article-title":"Fluphenazine induced Parkinson-like syndrome in a horse","volume":"22","author":"Brewer","year":"1990","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2025.08.011_bib74","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/j.cveq.2005.12.025","article-title":"Fluphenazine-induced extrapyramidal side effects in a horse","volume":"22","author":"Brashier","year":"2006","journal-title":"Vet Clin N Am Equine Pract"},{"issue":"2","key":"10.1016\/j.cveq.2025.08.011_bib75","first-page":"336","article-title":"Presumptive fluphenazine-induced hepatitis and urticaria in a horse","volume":"21","author":"Rodriguez-Palacios","year":"2007","journal-title":"J Vet Intern Med"},{"issue":"9","key":"10.1016\/j.cveq.2025.08.011_bib76","doi-asserted-by":"crossref","first-page":"980","DOI":"10.2460\/javma.1985.186.09.980","article-title":"Reserpine toxicosis in a horse","volume":"186","author":"Lloyd","year":"1985","journal-title":"J Am Vet Med Assoc"},{"issue":"6","key":"10.1016\/j.cveq.2025.08.011_bib77","first-page":"554","article-title":"Guanabenz in the horse\u2013A preliminary report on clinical effects and comparison to clonidine and other alpha-2 adrenergic agonists","volume":"38","author":"Lehner","year":"2022","journal-title":"PFERDEHEILKUNDE"},{"key":"10.1016\/j.cveq.2025.08.011_bib78","series-title":"\u03b12-Adrenergic agonists. Manual of equine anesthesia and analgesia","first-page":"188","author":"Skelding","year":"2021"},{"issue":"5","key":"10.1016\/j.cveq.2025.08.011_bib79","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.2042-3306.1986.tb03655.x","article-title":"Detomidine: a new sedative for horses","volume":"18","author":"Clark","year":"1986","journal-title":"Equine Vet J"},{"issue":"1-10","key":"10.1016\/j.cveq.2025.08.011_bib80","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1439-0442.1994.tb00120.x","article-title":"Effects of \u03b12-agonists on intrauterine pressure and sedation in horses: comparison between detomidine, romifidine and xylazine","volume":"41","author":"Schatzmann","year":"1994","journal-title":"J Vet Med Ser A"},{"key":"10.1016\/j.cveq.2025.08.011_bib81","first-page":"44","article-title":"Review of fatalities and adverse reactions after administration of \u03b1-2 adrenergic agonist reversal agents in the horse","author":"Scofield","year":"2010","journal-title":"Am Assoc Eq Pract Proceedings"},{"issue":"2","key":"10.1016\/j.cveq.2025.08.011_bib82","first-page":"106","article-title":"Evaluation of the interaction of mu and kappa opioid agonists on locomotor behavior in the horse","volume":"57","author":"Mama","year":"1993","journal-title":"Can J Vet Res"},{"issue":"3","key":"10.1016\/j.cveq.2025.08.011_bib83","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2460\/ajvr.68.3.246","article-title":"Effects of buprenorphine on nociception and spontaneous locomotor activity in horses","volume":"68","author":"Carregaro","year":"2007","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cveq.2025.08.011_bib84","first-page":"377","article-title":"The pharmacology of narcotic analgesics in the horse. IV. Dose and time response relationships for behavioral responses to morphine, meperidine, pentazocine, anileridine, methadone, and hydromorphone","volume":"3","author":"Combie","year":"1979","journal-title":"Narcotic Analgesics"},{"issue":"37","key":"10.1016\/j.cveq.2025.08.011_bib85","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.2174\/138161212803582469","article-title":"Non-analgesic effects of opioids: opioid-induced respiratory depression","volume":"18","author":"Boom","year":"2012","journal-title":"Curr Pharm Des"},{"issue":"8","key":"10.1016\/j.cveq.2025.08.011_bib86","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2460\/ajvr.2005.66.1420","article-title":"Effects of antitussive agents administered before bronchoalveolar lavage in horses","volume":"66","author":"Westermann","year":"2005","journal-title":"Am J Vet Res"},{"issue":"6","key":"10.1016\/j.cveq.2025.08.011_bib87","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2460\/ajvr.73.6.799","article-title":"Cardiorespiratory, gastrointestinal, and analgesic effects of morphine sulfate in conscious healthy horses","volume":"73","author":"Figueiredo","year":"2012","journal-title":"Am J Vet Res"},{"issue":"6","key":"10.1016\/j.cveq.2025.08.011_bib88","doi-asserted-by":"crossref","first-page":"992","DOI":"10.2460\/ajvr.67.6.992","article-title":"Evaluation of the effects of the opioid agonist morphine on gastrointestinal tract function in horses","volume":"67","author":"Boscan","year":"2006","journal-title":"Am J Vet Res"},{"issue":"2","key":"10.1016\/j.cveq.2025.08.011_bib89","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2460\/ajvr.2001.62.183","article-title":"Pharmacokinetics and adverse effects of butorphanol administered by single intravenous injection or continuous intravenous infusion in horses","volume":"62","author":"Sellon","year":"2001","journal-title":"Am J Vet Res"},{"issue":"12","key":"10.1016\/j.cveq.2025.08.011_bib90","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1590\/S0102-86502014001900006","article-title":"Effects of a continuous rate infusion of butorphanol in isoflurane-anesthetized horses on cardiorespiratory parameters, recovery quality, gastrointestinal motility and serum cortisol concentrations","volume":"29","author":"Dias","year":"2014","journal-title":"Acta Cir Bras"},{"issue":"11","key":"10.1016\/j.cveq.2025.08.011_bib91","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/vr.155.11.321","article-title":"Retrospectoive study the risk factors and prevalence of colic in horses after orthopaedic surgery","volume":"155","author":"Senior","year":"2004","journal-title":"Vet Rec"},{"key":"10.1016\/j.cveq.2025.08.011_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fpain.2024.1347548","article-title":"The impact of opioid administration on the incidence of postanaesthetic colic in horses","volume":"5","author":"Haralambus","year":"2024","journal-title":"Frontiers in Pain Research"},{"issue":"4","key":"10.1016\/j.cveq.2025.08.011_bib93","first-page":"339","article-title":"Atrial fibrillation in horses: factors associated with response to quinidine sulfate in 77 clinical cases","volume":"72","author":"Morris","year":"1982","journal-title":"Cornell Vet"},{"issue":"2","key":"10.1016\/j.cveq.2025.08.011_bib94","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1939-1676.1995.tb03274.x","article-title":"Treatment of atrial fibrillation in horses: new perspectives","volume":"9","author":"Reef","year":"1995","journal-title":"J Vet Intern Med"},{"issue":"1","key":"10.1016\/j.cveq.2025.08.011_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1939-1676.1988.tb01970.x","article-title":"Factors affecting prognosis and conversion in equine atrial fibrillation","volume":"2","author":"Reef","year":"1988","journal-title":"J Vet Intern Med"},{"issue":"11","key":"10.1016\/j.cveq.2025.08.011_bib96","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2460\/javma.252.11.1409","article-title":"Treatment of recent-onset atrial fibrillation with quinidine and flecainide in thoroughbred racehorses: 107 cases (1987\u20132014)","volume":"252","author":"Takahashi","year":"2018","journal-title":"J Am Vet Med Assoc"},{"issue":"S19","key":"10.1016\/j.cveq.2025.08.011_bib97","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.2042-3306.1995.tb04998.x","article-title":"Quinidine administration increases steady state serum digoxin concentration in horses","volume":"27","author":"Parraga","year":"1995","journal-title":"Equine Vet J"},{"issue":"1","key":"10.1016\/j.cveq.2025.08.011_bib98","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cveq.2018.11.004","article-title":"Cardiac therapeutics in horses","volume":"35","author":"Redpath","year":"2019","journal-title":"Vet Clin N Am Equine Pract"},{"issue":"4","key":"10.1016\/j.cveq.2025.08.011_bib99","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1476-4431.2010.00545.x","article-title":"Retrospective study: incidence of transfusion reactions to commercial equine plasma","volume":"20","author":"Hardefeldt","year":"2010","journal-title":"J Vet Emerg Crit Care"},{"issue":"2","key":"10.1016\/j.cveq.2025.08.011_bib100","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2460\/javma.231.2.267","article-title":"Clinical and clinicopathologic variables in adult horses receiving blood transfusions: 31 cases (1999\u20132005)","volume":"231","author":"Hurcombe","year":"2007","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.cveq.2025.08.011_bib101","unstructured":"AAoE Practitioners, USDA (United States dept of agriculture) and CFIA (Canadian food inspection agency) regulation of equine plasma & serum products for the equine practitioner white paper, 2002, American Association of Equine Practitioners White Paper. Availabe at: https:\/\/aaep.org\/publication\/aaep-plasma-white-paper\/."},{"issue":"5","key":"10.1016\/j.cveq.2025.08.011_bib102","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/evj.13477","article-title":"Equine parvovirus hepatitis","volume":"53","author":"Ramsauer","year":"2021","journal-title":"Equine Vet J"},{"issue":"7","key":"10.1016\/j.cveq.2025.08.011_bib103","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/jama.2013.430","article-title":"Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis","volume":"309","author":"Zarychanski","year":"2013","journal-title":"J Am Med Assoc"},{"issue":"1","key":"10.1016\/j.cveq.2025.08.011_bib104","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/bja\/aet303","article-title":"Incidence of postoperative death and acute kidney injury associated with iv 6% hydroxyethyl starch use: systematic review and meta-analysis","volume":"112","author":"Gillies","year":"2014","journal-title":"Br J Anaesth"},{"issue":"1","key":"10.1016\/j.cveq.2025.08.011_bib105","doi-asserted-by":"crossref","first-page":"185.e1","DOI":"10.1016\/j.jcrc.2013.09.031","article-title":"Fluid resuscitation with hydroxyethyl starches in patients with sepsis is associated with an increased incidence of acute kidney injury and use of renal replacement therapy: a systematic review and meta-analysis of the literature","volume":"29","author":"Neto","year":"2014","journal-title":"J Crit Care"},{"issue":"7","key":"10.1016\/j.cveq.2025.08.011_bib106","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1538-7836.2009.03460.x","article-title":"Mechanisms of hydroxyethyl starch-induced dilutional coagulopathy","volume":"7","author":"Eriksen","year":"2009","journal-title":"J Thromb Haemostasis"},{"issue":"7","key":"10.1016\/j.cveq.2025.08.011_bib107","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2460\/javma.2001.218.1130","article-title":"Effect of hydroxyethyl starch infusion on colloid oncotic pressure in hypoproteinemic horses","volume":"218","author":"Jones","year":"2001","journal-title":"J Am Vet Med Assoc"},{"issue":"5","key":"10.1016\/j.cveq.2025.08.011_bib108","doi-asserted-by":"crossref","first-page":"712","DOI":"10.2460\/ajvr.74.5.712","article-title":"In vitro effects of three formulations of hydroxyethyl starch solutions on coagulation and platelet function in horses","volume":"74","author":"Blong","year":"2013","journal-title":"Am J Vet Res"},{"issue":"1","key":"10.1016\/j.cveq.2025.08.011_bib109","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/jvim.12245","article-title":"Cardiovascular, colloid osmotic pressure, and hemostatic effects of 2 formulations of hydroxyethyl starch in healthy horses","volume":"28","author":"Epstein","year":"2014","journal-title":"J Vet Intern Med"},{"issue":"6","key":"10.1016\/j.cveq.2025.08.011_bib110","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/evj.12223","article-title":"Coagulation, oncotic and haemodilutional effects of a third-generation hydroxyethyl starch (130\/0.4) solution in horses","volume":"46","author":"Viljoen","year":"2014","journal-title":"Equine Vet J"},{"issue":"10","key":"10.1016\/j.cveq.2025.08.011_bib111","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1439-0442.2007.01007.x","article-title":"Effect of hydroxyethyl starch solution in normal horses and horses with colic or acute colitis","volume":"54","author":"Schusser","year":"2007","journal-title":"J Vet Med Ser A"},{"issue":"3","key":"10.1016\/j.cveq.2025.08.011_bib112","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/evj.12594","article-title":"A comparison of the effects of a 4% modified fluid gelatin and a 6% hydroxyethyl starch on haemodilution, colloid osmotic pressure, haemostasis and renal parameters in healthy ponies","volume":"49","author":"Gratwick","year":"2017","journal-title":"Equine Vet J"},{"issue":"10","key":"10.1016\/j.cveq.2025.08.011_bib113","first-page":"1069","article-title":"Effects of administration of a synthetic low molecular weight\/low molar substitution hydroxyethyl starch solution in healthy neonatal foals","volume":"56","author":"Hepworth-Warren","year":"2015","journal-title":"Can Vet J"},{"issue":"4","key":"10.1016\/j.cveq.2025.08.011_bib114","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1467-2995.2005.00201.x","article-title":"Investigation of the EEG effects of intravenous lidocaine during halothane anaesthesia in ponies","volume":"32","author":"Murrell","year":"2005","journal-title":"Vet Anaesth Analg"},{"issue":"10","key":"10.1016\/j.cveq.2025.08.011_bib115","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1213\/00000539-198510000-00005","article-title":"Inhibition of postoperative pain by continuous low-dose intravenous infusion of lidocaine","volume":"64","author":"Cassuto","year":"1985","journal-title":"Anesth Analg"},{"issue":"1\u20132","key":"10.1016\/j.cveq.2025.08.011_bib116","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.vetimm.2008.12.017","article-title":"The effect of lidocaine on in vitro adhesion and migration of equine neutrophils","volume":"129","author":"Cook","year":"2009","journal-title":"Vet Immunol Immunopathol"},{"issue":"4","key":"10.1016\/j.cveq.2025.08.011_bib117","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/j.1939-1676.2010.0555.x","article-title":"Effects of lidocaine infusion during experimental endotoxemia in horses","volume":"24","author":"Peir\u00f3","year":"2010","journal-title":"J Vet Intern Med"},{"issue":"3","key":"10.1016\/j.cveq.2025.08.011_bib118","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1435-6935.2003.00080.x","article-title":"Use of intravenous lidocaine to prevent reperfusion injury and subsequent multiple organ dysfunction syndrome","volume":"13","author":"Cassutto","year":"2003","journal-title":"J Vet Emerg Crit Care"},{"issue":"6","key":"10.1016\/j.cveq.2025.08.011_bib119","first-page":"736","article-title":"Intravenous lidocaine and small-intestinal size, abdominal fluid, and outcome after colic surgery in horses","volume":"16","author":"Brianceau","year":"2002","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.cveq.2025.08.011_bib120","first-page":"133","article-title":"Intravenous lidocaine infusion in balanced anaesthesia for abdominal surgery: update and clinical experiences","volume":"21","author":"Driessen","year":"2005","journal-title":"Pferdeheikunde"},{"issue":"3","key":"10.1016\/j.cveq.2025.08.011_bib121","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1939-1676.2009.0311.x","article-title":"Risk factors for equine postoperative ileus and effectiveness of prophylactic lidocaine","volume":"23","author":"Torfs","year":"2009","journal-title":"J Vet Intern Med"},{"issue":"1","key":"10.1016\/j.cveq.2025.08.011_bib122","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1532-950X.2005.00113.x","article-title":"Intravenous continuous infusion of lidocaine for treatment of equine ileus","volume":"35","author":"Malone","year":"2006","journal-title":"Vet Surg"},{"issue":"6","key":"10.1016\/j.cveq.2025.08.011_bib123","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/evj.12520","article-title":"Clinical features and management of equine post operative ileus (POI): survey of diplomates of the American Colleges of Veterinary Internal Medicine (ACVIM), Veterinary Surgeons (ACVS) and Veterinary Emergency and Critical Care (ACVECC)","volume":"48","author":"Lefebvre","year":"2016","journal-title":"Equine Vet J"},{"issue":"4","key":"10.1016\/j.cveq.2025.08.011_bib124","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.2042-3306.1998.tb04101.x","article-title":"Effect of intravenous lidocaine on halothane minimum alveolar concentration in ponies","volume":"30","author":"Doherty","year":"1998","journal-title":"Equine Vet J"},{"issue":"4","key":"10.1016\/j.cveq.2025.08.011_bib125","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1439-0442.2003.00523.x","article-title":"Effects of intravenous lidocaine on isoflurane concentration, physiological parameters, metabolic parameters and stress-related hormones in horses undergoing surgery","volume":"50","author":"Dzikiti","year":"2003","journal-title":"J Vet Med Ser A"},{"issue":"2","key":"10.1016\/j.cveq.2025.08.011_bib126","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/vaa.12192","article-title":"Clinical comparison of two regimens of lidocaine infusion in horses undergoing laparotomy for colic","volume":"42","author":"Nannarone","year":"2015","journal-title":"Vet Anaesth Analg"},{"issue":"4","key":"10.1016\/j.cveq.2025.08.011_bib127","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1467-2995.2007.00391.x","article-title":"Clinical evaluation of ketamine and lidocaine intravenous infusions to reduce isoflurane requirements in horses under general anaesthesia","volume":"35","author":"Enderle","year":"2008","journal-title":"Vet Anaesth Analg"},{"issue":"4","key":"10.1016\/j.cveq.2025.08.011_bib128","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2460\/ajvr.72.4.446","article-title":"Effects of intravenous administration of lidocaine on the minimum alveolar concentration of sevoflurane in horses","volume":"72","author":"Rezende","year":"2011","journal-title":"Am J Vet Res"},{"issue":"5","key":"10.1016\/j.cveq.2025.08.011_bib129","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2746\/042516401776254871","article-title":"Effects of intravenous lidocaine overdose on cardiac electrical activity and blood pressure in the horse","volume":"33","author":"Meyer","year":"2001","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2025.08.011_bib130","series-title":"Boehringer ingelheim animal health","year":"2021"},{"key":"10.1016\/j.cveq.2025.08.011_bib131","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jevs.2017.07.007","article-title":"Effect of pergolide therapy on semen parameters in a stallion with pituitary pars intermedia dysfunction","volume":"58","author":"Ujvari","year":"2017","journal-title":"J Equine Vet Sci"},{"issue":"3","key":"10.1016\/j.cveq.2025.08.011_bib132","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2460\/javma.234.3.385","article-title":"Effects of compounding and storage conditions on stability of pergolide mesylate","volume":"234","author":"Davis","year":"2009","journal-title":"J Am Vet Med Assoc"},{"issue":"7","key":"10.1016\/j.cveq.2025.08.011_bib133","article-title":"Equine pergolide toxicity: a case series","volume":"16","author":"Ebeling-Koning","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.cveq.2025.08.011_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.domaniend.2024.106894","article-title":"Short-term clinical and biochemical responses following treatment with dapagliflozin or ertugliflozin in horses with hyperinsulinemia: a retrospective case series","volume":"90","author":"Sundra","year":"2025","journal-title":"Domest Anim Endocrinol"},{"issue":"4","key":"10.1016\/j.cveq.2025.08.011_bib135","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/evj.13944","article-title":"Sodium\u2013glucose cotransporter 2 inhibitors in horses\u2014magic bullet or latest fad","volume":"55","author":"Sundra","year":"2023","journal-title":"Equine Vet J"},{"issue":"3","key":"10.1016\/j.cveq.2025.08.011_bib136","doi-asserted-by":"crossref","first-page":"365","DOI":"10.5455\/OVJ.2023.v13.i3.14","article-title":"Hypertriglyceridemia in equines with refractory hyperinsulinemia treated with SGLT2 inhibitors","volume":"13","author":"Kellon","year":"2023","journal-title":"Open Vet J"},{"issue":"6","key":"10.1016\/j.cveq.2025.08.011_bib137","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/eve.13738","article-title":"Preliminary observations on the use of ertugliflozin in the management of hyperinsulinaemia and laminitis in 51 horses: a case series","volume":"35","author":"Sundra","year":"2023","journal-title":"Equine Vet Educ"}],"container-title":["Veterinary Clinics of North America: Equine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749073925000549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749073925000549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T06:21:52Z","timestamp":1762582912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749073925000549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":137,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0749073925000549"],"URL":"https:\/\/doi.org\/10.1016\/j.cveq.2025.08.011","relation":{},"ISSN":["0749-0739"],"issn-type":[{"value":"0749-0739","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse Effects and Drug Reactions in Equids","name":"articletitle","label":"Article Title"},{"value":"Veterinary Clinics of North America: Equine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cveq.2025.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}